Spots Global Cancer Trial Database for fluorodeoxyglucose
Every month we try and update this database with for fluorodeoxyglucose cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
PET TDM FDG-Choline as a Decision-making Tool for Routine Care on the Liver Transplant List for HCC | NCT04792801 | Hepatocellular ... Liver Transplan... | PET TDM FDG-Cho... | 18 Years - | University Hospital, Lille | |
18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and Neurology | NCT01180751 | Tumors | [18F]-Fluorodeo... | 18 Years - | University of Manitoba | |
PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial) | NCT00201942 | Breast Cancer | PET scan | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
Fludeoxyglucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Cervical Heterogenity Imaging Study | NCT00907140 | Cervical Cancer | Positron Emissi... | 18 Years - 100 Years | Washington University School of Medicine | |
Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular Markers | NCT02600442 | Breast Neoplasm... Breast Cancer | non interventio... | - | Assistance Publique - Hôpitaux de Paris | |
PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma | NCT00828126 | Melanoma | PET-CT Scan | 18 Years - | M.D. Anderson Cancer Center | |
18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and Neurology | NCT01180751 | Tumors | [18F]-Fluorodeo... | 18 Years - | University of Manitoba | |
PET TDM FDG-Choline as a Decision-making Tool for Routine Care on the Liver Transplant List for HCC | NCT04792801 | Hepatocellular ... Liver Transplan... | PET TDM FDG-Cho... | 18 Years - | University Hospital, Lille | |
PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial) | NCT00201942 | Breast Cancer | PET scan | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
PET TDM FDG-Choline as a Decision-making Tool for Routine Care on the Liver Transplant List for HCC | NCT04792801 | Hepatocellular ... Liver Transplan... | PET TDM FDG-Cho... | 18 Years - | University Hospital, Lille | |
Pinverin Application Trial to Reduce Bowel Uptake of FDG (Fluorodeoxyglucose) | NCT02173964 | Cancer | pinaverium brom... water | 19 Years - 80 Years | Seoul National University Hospital | |
Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular Markers | NCT02600442 | Breast Neoplasm... Breast Cancer | non interventio... | - | Assistance Publique - Hôpitaux de Paris | |
Fludeoxyglucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Cervical Heterogenity Imaging Study | NCT00907140 | Cervical Cancer | Positron Emissi... | 18 Years - 100 Years | Washington University School of Medicine | |
Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer | NCT00464282 | Carcinoma, Non-... | 8 Months - 2 Years | Gunma University |